Loading clinical trials...
Loading clinical trials...
Influence of Single Nucleotide Polymorphisms of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects: A Phase II, Multicenter, Double-blind Study
Conditions
Interventions
Perindopril
Locations
13
Portugal
Unidade de Saúde Familiar Escariz
Arouca, Portugal
Centro Hospitalar do Baixo Vouga (CHBV), EPE
Aveiro, Portugal
Unidade de Saúde Familiar Canelas
Canelas, Portugal
Centro Hospitalar Cova da Beira (CHCB), EPE
Covilha, Portugal
Unidade de Saúde Familiar Lethes
Ponte de Lima, Portugal
Centro Hospitalar de São João (CHSJ), E.P.E
Porto, Portugal
Start Date
February 18, 2016
Primary Completion Date
January 18, 2017
Completion Date
April 27, 2017
Last Updated
August 3, 2017
NCT07472881
NCT01143454
NCT07010757
NCT06989203
NCT06223555
NCT07237750
Lead Sponsor
Gene PreDiT
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions